{"id":5097,"date":"2026-06-04T03:20:20","date_gmt":"2026-06-04T03:20:20","guid":{"rendered":"https:\/\/trg.unhas.ac.id\/pharmaepid\/?p=5097"},"modified":"2026-06-04T03:20:22","modified_gmt":"2026-06-04T03:20:22","slug":"breaking-the-silence-on-tuberculosis-what-indonesians-know-and-what-still-needs-to-change","status":"publish","type":"post","link":"https:\/\/trg.unhas.ac.id\/pharmaepid\/2026\/06\/04\/breaking-the-silence-on-tuberculosis-what-indonesians-know-and-what-still-needs-to-change\/","title":{"rendered":"Breaking the Silence on Tuberculosis: What Indonesians Know\u2014and What Still Needs to Change"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">MAKASSAR, Indonesia Apr 24 2026 \/PharmaEpid RG\/\u2013 Tuberculosis (TB) remains one of the most serious public health challenges in Indonesia. Despite global efforts to eliminate the disease, Indonesia still ranks among the countries with the highest TB burden. Beyond medical treatment, one critical factor often overlooked is how well people understand the disease itself. Knowledge, attitudes, and perceptions within the community play a vital role in preventing transmission and improving treatment outcomes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A recent study titled <strong>\u201cKnowledge, Attitudes, and Perceptions of Tuberculosis in Indonesia: A Multi-Center Cross-Sectional Study\u201d<\/strong> (<strong>Publisher: Taylor &amp; Francis<\/strong>), published in <em>Infection and Drug Resistance<\/em> on <strong>December 31, 2023<\/strong>, by Silma Kaaffah and colleagues, provides important insights into how Indonesians perceive TB. The study involved 3,205 participants from all 34 provinces, making it one of the most comprehensive national assessments to date.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-1024x768.png\" alt=\"\" class=\"wp-image-4853\" srcset=\"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-1024x768.png 1024w, https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-300x225.png 300w, https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-768x576.png 768w, https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d.png 1448w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The findings are both encouraging and concerning. More than half of participants (56.4%) demonstrated high knowledge about TB, and an impressive 91% showed positive attitudes toward the disease. However, only 38% had a strong perception, meaning that misconceptions and stigma still persist in society . For example, while many respondents understood that TB is curable, some still believed incorrect information about how it spreads or how long treatment should last.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This gap between knowledge and perception is crucial. As illustrated in the graphical summary on page 3 of the article, even though awareness is relatively high, misunderstandings about transmission and treatment remain widespread. These misconceptions can lead to delayed diagnosis, poor treatment adherence, and continued spread of the disease. In some cases, stigma causes patients to avoid seeking care altogether, worsening both individual and public health outcomes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The importance of this research lies in its ability to highlight that fighting TB is not only a medical issue but also a social and educational challenge. Improving public understanding can directly influence behavior\u2014encouraging early diagnosis, adherence to treatment, and reducing stigma. The study emphasizes that targeted health education, especially in rural areas and lower-income populations, is essential for effective TB control.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This research strongly aligns with global development priorities. It supports <strong>SDG 3 (Good Health and Well-being)<\/strong> by promoting disease prevention and improving healthcare outcomes. It also contributes to <strong>SDG 4 (Quality Education)<\/strong> by emphasizing the need for public health literacy. Addressing misinformation and stigma can reduce healthcare inequalities, linking to <strong>SDG 1 (No Poverty)<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In conclusion, Indonesia has made progress in raising awareness about tuberculosis, but challenges remain. Bridging the gap between knowledge and perception is the next critical step. With stronger education, community engagement, and collaborative efforts, Indonesia can move closer to its goal of eliminating TB by 2035.<\/p>\n\n\n\n<pre class=\"wp-block-preformatted\"><strong>Reference:<\/strong><\/pre>\n\n\n\n<p class=\"wp-block-paragraph\">DOI: <a href=\"https:\/\/doi.org\/10.2147\/IDR.S404171\">https:\/\/doi.org\/10.2147\/IDR.S404171&nbsp;<\/a><\/p>\n\n\n\n<pre class=\"wp-block-preformatted\"><strong>Contact:<\/strong>\nMuh. Akbar Bahar, Ph.D\n+62 819-4422-8642\nakbarbahar@unhas.ac.id<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>MAKASSAR, Indonesia Apr 24 2026 \/PharmaEpid RG\/\u2013 Tuberculosis (TB) remains one of the most serious public health challenges in Indonesia. Despite global efforts to eliminate the disease, Indonesia still ranks among the countries with the highest TB burden. Beyond medical treatment, one critical factor often overlooked is how well people understand the disease itself. Knowledge, [&hellip;]<\/p>\n","protected":false},"author":287,"featured_media":4853,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[1],"tags":[39,41,42],"class_list":["post-5097","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-sdg1","tag-sdg3","tag-sdg4"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d.png",1448,1086,false],"thumbnail":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-150x150.png",150,150,true],"medium":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-300x225.png",300,225,true],"medium_large":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-768x576.png",768,576,true],"large":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-1024x768.png",1024,768,true],"1536x1536":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d.png",1448,1086,false],"2048x2048":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d.png",1448,1086,false]},"uagb_author_info":{"display_name":"adminpharma","author_link":"https:\/\/trg.unhas.ac.id\/pharmaepid\/author\/adminpharma\/"},"uagb_comment_info":0,"uagb_excerpt":"MAKASSAR, Indonesia Apr 24 2026 \/PharmaEpid RG\/\u2013 Tuberculosis (TB) remains one of the most serious public health challenges in Indonesia. Despite global efforts to eliminate the disease, Indonesia still ranks among the countries with the highest TB burden. Beyond medical treatment, one critical factor often overlooked is how well people understand the disease itself. Knowledge,&hellip;","rttpg_featured_image_url":{"full":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d.png",1448,1086,false],"landscape":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d.png",1448,1086,false],"portraits":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d.png",1448,1086,false],"thumbnail":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-150x150.png",150,150,true],"medium":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-300x225.png",300,225,true],"large":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d-1024x768.png",1024,768,true],"1536x1536":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d.png",1448,1086,false],"2048x2048":["https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-content\/uploads\/sites\/323\/2026\/04\/4f239d2b-467d-467d-b30b-511ddd24057d.png",1448,1086,false]},"rttpg_author":{"display_name":"adminpharma","author_link":"https:\/\/trg.unhas.ac.id\/pharmaepid\/author\/adminpharma\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/trg.unhas.ac.id\/pharmaepid\/category\/uncategorized\/\" rel=\"category tag\">Uncategorized<\/a>","rttpg_excerpt":"MAKASSAR, Indonesia Apr 24 2026 \/PharmaEpid RG\/\u2013 Tuberculosis (TB) remains one of the most serious public health challenges in Indonesia. Despite global efforts to eliminate the disease, Indonesia still ranks among the countries with the highest TB burden. Beyond medical treatment, one critical factor often overlooked is how well people understand the disease itself. Knowledge,&hellip;","_links":{"self":[{"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/posts\/5097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/users\/287"}],"replies":[{"embeddable":true,"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/comments?post=5097"}],"version-history":[{"count":1,"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/posts\/5097\/revisions"}],"predecessor-version":[{"id":5098,"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/posts\/5097\/revisions\/5098"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/media\/4853"}],"wp:attachment":[{"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/media?parent=5097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/categories?post=5097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trg.unhas.ac.id\/pharmaepid\/wp-json\/wp\/v2\/tags?post=5097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}